On December 15, 2024, Pharming Technologies B.V. ("Pharming”), a wholly-owned subsidiary of Pharming Group N.V., announced a ...
Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) ...
Positive Interim Analysis of the FALCON Study 2024 SummaryImportant events during 2024KL1333In July, Abliva announced a positive outcome of the interim analysis of the 24-week data of the FALCON study ...
Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following ...
A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website. For more information about this conference ...
A live webcast and replay of the presentation will be available in the "Upcoming Events” and "News” sections of Pharming's website. For more information about this conference, or to schedule a ...
Recent global market developments have been marked by tariff uncertainties and mixed economic signals, with U.S. stocks experiencing a decline amid trade tensions and cooling job growth, while ...
Staying aware of cyberattacks and how to recognize and prevent them can significantly reduce the impact of the human element in risk management and, ultimately, lower the amount of successful data ...